Published in J Biol Chem on May 07, 1999
Series introduction: the transcription factor NF-kappaB and human disease. J Clin Invest (2001) 4.18
Hostile takeovers: viral appropriation of the NF-kappaB pathway. J Clin Invest (2001) 3.28
The IRF-3 transcription factor mediates Sendai virus-induced apoptosis. J Virol (2000) 2.13
Molecular pathways in virus-induced cytokine production. Microbiol Mol Biol Rev (2001) 1.97
NF-kappaB family of transcription factors: central regulators of innate and adaptive immune functions. Clin Microbiol Rev (2002) 1.97
Ubiquitination and auxin signaling: a degrading story. Plant Cell (2002) 1.85
IkappaBbeta is an essential co-activator for LPS-induced IL-1beta transcription in vivo. J Exp Med (2010) 1.15
RelA/p65 regulation of IkappaBbeta. Mol Cell Biol (2005) 0.99
Inhibition of NF-kappaB activity by IkappaBbeta in association with kappaB-Ras. Mol Cell Biol (2004) 0.96
The human cytomegalovirus virion possesses an activated casein kinase II that allows for the rapid phosphorylation of the inhibitor of NF-kappaB, IkappaBalpha. J Virol (2007) 0.94
Stromal down-regulation of macrophage CD4/CCR5 expression and NF-κB activation mediates HIV-1 non-permissiveness in intestinal macrophages. PLoS Pathog (2011) 0.92
Effects of β(2) Agonists, Corticosteroids, and Novel Therapies on Rhinovirus-Induced Cytokine Release and Rhinovirus Replication in Primary Airway Fibroblasts. J Allergy (Cairo) (2011) 0.86
Caveolin-1 suppresses human immunodeficiency virus-1 replication by inhibiting acetylation of NF-κB. Virology (2012) 0.83
Viral subversion mechanisms in chronic kidney disease pathogenesis. Clin J Am Soc Nephrol (2007) 0.82
OX40:OX40L axis: emerging targets for improving poxvirus-based CD8(+) T-cell vaccines against respiratory viruses. Immunol Rev (2011) 0.82
Analysis of SRrp86-regulated alternative splicing: control of c-Jun and IκBβ activity. RNA Biol (2010) 0.77
Human immunodeficiency virus type 1 Vpu and cellular TASK proteins suppress transcription of unintegrated HIV-1 DNA. Virol J (2012) 0.76
Persistent activation of NF-kappaB related to IkappaB's degradation profiles during early chemical hepatocarcinogenesis. J Carcinog (2007) 0.75
Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol Cell Biol (1998) 7.43
Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappa B by phosphorylating I kappa B. Proc Natl Acad Sci U S A (1994) 4.53
The growing family of interferon regulatory factors. Cytokine Growth Factor Rev (1997) 3.33
Regulation of type I interferon gene expression by interferon regulatory factor-3. J Biol Chem (1998) 3.31
Essential role of interferon regulatory factor 3 in direct activation of RANTES chemokine transcription. Mol Cell Biol (1999) 3.12
Selective DNA binding and association with the CREB binding protein coactivator contribute to differential activation of alpha/beta interferon genes by interferon regulatory factors 3 and 7. Mol Cell Biol (2000) 3.00
Interferon regulatory factors: the next generation. Gene (1999) 2.98
Structural and functional analysis of interferon regulatory factor 3: localization of the transactivation and autoinhibitory domains. Mol Cell Biol (1999) 2.93
Primary activation of interferon A and interferon B gene transcription by interferon regulatory factor 3. Proc Natl Acad Sci U S A (1998) 2.69
Identification of distinct signaling pathways leading to the phosphorylation of interferon regulatory factor 3. J Biol Chem (2001) 2.47
Multiple regulatory domains control IRF-7 activity in response to virus infection. J Biol Chem (2000) 2.20
The IRF-3 transcription factor mediates Sendai virus-induced apoptosis. J Virol (2000) 2.13
Regulation of RANTES chemokine gene expression requires cooperativity between NF-kappa B and IFN-regulatory factor transcription factors. J Immunol (2000) 2.02
Identification of a novel glucocorticoid response element within the genome of the human immunodeficiency virus type 1. Virology (1993) 1.94
HHV-8 encoded vIRF-1 represses the interferon antiviral response by blocking IRF-3 recruitment of the CBP/p300 coactivators. Oncogene (2001) 1.94
Phosphorylation of IkappaBalpha in the C-terminal PEST domain by casein kinase II affects intrinsic protein stability. Mol Cell Biol (1996) 1.90
Generation of drug-resistant variants of human immunodeficiency virus type 1 by in vitro passage in increasing concentrations of 2',3'-dideoxycytidine and 2',3'-dideoxy-3'-thiacytidine. Antimicrob Agents Chemother (1993) 1.86
Differential expression of human interferon genes. Nucleic Acids Res (1984) 1.82
Regulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factors. Microbiol Rev (1995) 1.63
Viral induction of the human beta interferon promoter: modulation of transcription by NF-kappa B/rel proteins and interferon regulatory factors. J Virol (1994) 1.51
Synergism between distinct enhanson domains in viral induction of the human beta interferon gene. Mol Cell Biol (1990) 1.46
Mutational analysis of interferon (IFN) regulatory factors 1 and 2. Effects on the induction of IFN-beta gene expression. J Biol Chem (1994) 1.45
Amplification and rearrangement of integrated SV40 DNA sequences accompany the selection of anchorage-independent transformed mouse cells. Cell (1980) 1.38
Induction of IRF-3 and IRF-7 phosphorylation following activation of the RIG-I pathway. Cell Mol Biol (Noisy-le-grand) (2006) 1.33
I kappaB alpha physically interacts with a cytoskeleton-associated protein through its signal response domain. Mol Cell Biol (1997) 1.31
Interferon activation and innate immunity. Rev Immunogenet (2000) 1.31
Multiple protein-DNA interactions within the human interferon-beta regulatory element. J Biol Chem (1989) 1.28
Role of the interferon regulatory factors (IRFs) in virus-mediated signaling and regulation of cell growth. Biochimie (1999) 1.26
Inducible expression of IkappaBalpha repressor mutants interferes with NF-kappaB activity and HIV-1 replication in Jurkat T cells. J Biol Chem (1998) 1.23
Disruption of NF-kappaB signaling reveals a novel role for NF-kappaB in the regulation of TNF-related apoptosis-inducing ligand expression. J Immunol (2001) 1.23
Biological and biochemical inhibitors of the NF-kappa B/Rel proteins and cytokine synthesis. Cytokine Growth Factor Rev (1996) 1.17
Differential transcriptional activation in vitro by NF-kappa B/Rel proteins. J Biol Chem (1995) 1.15
Posttranslational regulation of IRF-4 activity by the immunophilin FKBP52. Immunity (2000) 1.15
Quantitative PCR analysis of TNF-alpha and IL-1 beta mRNA levels in pediatric IBD mucosal biopsies. Dig Dis Sci (1997) 1.14
IFN-beta induces serine phosphorylation of Stat-1 in Ewing's sarcoma cells and mediates apoptosis via induction of IRF-1 and activation of caspase-7. Oncogene (2000) 1.14
Overproduction of NFKB2 (lyt-10) and c-Rel: a mechanism for HTLV-I Tax-mediated trans-activation via the NF-kappa B signalling pathway. Oncogene (1994) 1.12
Human herpesvirus 6 induces interleukin-1 beta and tumor necrosis factor alpha, but not interleukin-6, in peripheral blood mononuclear cell cultures. J Virol (1991) 1.11
Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication. J Virol (1996) 1.11
Cell-specific differences in activation of NF-kappa B regulatory elements of human immunodeficiency virus and beta interferon promoters by tumor necrosis factor. J Virol (1990) 1.10
Coordinate enhancement of cytokine gene expression in human immunodeficiency virus type 1-infected promonocytic cells. J Virol (1990) 1.09
Modulatory effects of Epstein-Barr, herpes simplex, and human herpes-6 viral infections and coinfections on cytokine synthesis. A comparative study. J Immunol (1992) 1.09
IkappaB-mediated inhibition of virus-induced beta interferon transcription. J Virol (1999) 1.09
Organization of the human tarbp2 gene reveals two promoters that are repressed in an astrocytic cell line. J Biol Chem (2001) 1.09
Activation of multiple growth regulatory genes following inducible expression of IRF-1 or IRF/RelA fusion proteins. Oncogene (1997) 1.09
A role for casein kinase II phosphorylation in the regulation of IRF-1 transcriptional activity. Mol Cell Biochem (1999) 1.08
The interferon-inducible protein kinase PKR modulates the transcriptional activation of immunoglobulin kappa gene. J Biol Chem (1995) 1.03
Chronic human immunodeficiency virus type 1 infection stimulates distinct NF-kappa B/rel DNA binding activities in myelomonoblastic cells. J Virol (1993) 1.03
Sequence elements downstream of the human immunodeficiency virus type 1 long terminal repeat are required for efficient viral gene transcription. J Mol Biol (1997) 1.01
Induction of monocytic differentiation and NF-kappa B-like activities by human immunodeficiency virus 1 infection of myelomonoblastic cells. J Exp Med (1992) 1.01
Transcription factor IRF-2 exerts its oncogenic phenotype through the DNA binding/transcription repression domain. Oncogene (1995) 1.01
Infection of peripheral blood mononuclear cells by herpes simplex and Epstein-Barr viruses. Differential induction of interleukin 6 and tumor necrosis factor-alpha. J Clin Invest (1992) 1.00
Diminution of CD4 surface protein but not CD4 messenger RNA levels in monocytic cells infected by HIV-1. AIDS (1991) 1.00
Identification by in vivo genomic footprinting of a transcriptional switch containing NF-kappaB and Sp1 that regulates the IkappaBalpha promoter. Mol Cell Biol (1999) 1.00
The role of the C-terminal domain of I kappa B alpha in protein degradation and stabilization. J Biol Chem (1996) 1.00
Inhibition of tumor necrosis factor-alpha transcription by Epstein-Barr virus. Eur J Immunol (1991) 1.00
Increased DNA synthesis and repair-enzyme expression in lymphocytes from patients with chronic lymphocytic leukemia resistant to nitrogen mustards. J Natl Cancer Inst (1991) 0.99
Oncolytic activity of vesicular stomatitis virus in primary adult T-cell leukemia. Oncogene (2006) 0.99
Constitutive phosphorylation and turnover of I kappa B alpha in human T-cell leukemia virus type I-infected and Tax-expressing T cells. J Virol (1995) 0.98
Disruption of I kappa B alpha regulation by antisense RNA expression leads to malignant transformation. Oncogene (1994) 0.97
Retinoic acid is able to induce interferon regulatory factor 1 in squamous carcinoma cells via a STAT-1 independent signalling pathway. Cell Growth Differ (1999) 0.97
Activation of cytokine genes in HIV-1 infected myelomonoblastic cells by phorbol ester and tumor necrosis factor. J Immunol (1992) 0.95
NF-kappa B activity in T cells stably expressing the Tax protein of human T cell lymphotropic virus type I. Virology (1991) 0.95
Enhancing VSV oncolytic activity with an improved cytosine deaminase suicide gene strategy. Cancer Gene Ther (2011) 0.94
Colonic explant production of IL-1and its receptor antagonist is imbalanced in inflammatory bowel disease (IBD). Clin Exp Immunol (1998) 0.93
Molecular mechanisms regulating induction of interleukin-6 gene transcription by interferon-gamma. Eur J Immunol (1997) 0.93
Molecular interactions between HTLV-1 Tax protein and the NF-kappa B/kappa B transcription complex. Virology (1995) 0.92
Subcellular redistribution of HTLV-1 Tax protein by NF-kappa B/Rel transcription factors. Virology (1994) 0.92
Activation of the I kappa B alpha kinase (IKK) complex by double-stranded RNA-binding defective and catalytic inactive mutants of the interferon-inducible protein kinase PKR. Oncogene (2001) 0.92
Characterization of TH3, an induction-specific protein interacting with the interferon beta promoter. Virology (1992) 0.92
Induction of CD4 expression and human immunodeficiency virus type 1 replication by mutants of the interferon-inducible protein kinase PKR. J Virol (1997) 0.91
IRF regulation of HIV-1 long terminal repeat activity. J Interferon Cytokine Res (2002) 0.90
Activation and repression of the 2-5A synthetase and p21 gene promoters by IRF-1 and IRF-2. Oncogene (1999) 0.90
Activation and regulation of interferon regulatory factor 4 in HTLV type 1-infected T lymphocytes. AIDS Res Hum Retroviruses (2000) 0.89
Selective inhibition of l kappaB alpha phosphorylation and HIV-1 LTR-directed gene expression by novel antioxidant compounds. Virology (1997) 0.89
The eukaryotic translation initiation factor eIF4E is a direct transcriptional target of NF-κB and is aberrantly regulated in acute myeloid leukemia. Leukemia (2013) 0.89
The limited role of the human interferon system response to respiratory syncytial virus challenge: analysis and comparison to influenza virus challenge. Microb Pathog (1992) 0.88
Lipopolysaccharide inhibits virus-mediated induction of interferon genes by disruption of nuclear transport of interferon regulatory factors 3 and 7. J Biol Chem (1999) 0.88
Chronic human immunodeficiency virus type 1 infection of myeloid cells disrupts the autoregulatory control of the NF-kappaB/Rel pathway via enhanced IkappaBalpha degradation. J Virol (1996) 0.88
NF-kappaB activation and HIV-1 induced apoptosis. Cytokine Growth Factor Rev (2000) 0.88
Taxol selectively blocks microtubule dependent NF-kappaB activation by phorbol ester via inhibition of IkappaBalpha phosphorylation and degradation. Oncogene (1999) 0.87
NF-kappaB protects HIV-1-infected myeloid cells from apoptosis. Virology (1998) 0.85
Transient expression of the beta interferon promoter in human cells. Mol Cell Biol (1987) 0.85
Identification of a nuclear DNA binding protein associated with the interferon-beta upstream regulatory region. J Biol Chem (1987) 0.84
Human T cell leukemia virus type 1 tax protein increases NF-kappa B dimer formation and antagonizes the inhibitory activity of the I kappa B alpha regulatory protein. Virology (1996) 0.84
A developmentally regulated octamer-binding activity in embryonal carcinoma cells which represses beta-interferon expression. Cell Growth Differ (1991) 0.83
Activation of the wt1 Wilms' tumor suppressor gene by NF-kappaB. Oncogene (1998) 0.82
Induction of relA(p65) and I kappa B alpha subunit expression during differentiation of human peripheral blood monocytes to macrophages. Cell Growth Differ (1997) 0.82
Identification of the secretory leukocyte protease inhibitor (SLPI) as a target of IRF-1 regulation. Oncogene (1999) 0.81
Stimulation of interferon beta gene transcription in vitro by purified NF-kappa B and a novel TH protein. Cell Growth Differ (1991) 0.81
Differential susceptibilities of U-937 cell clones to infection by human immunodeficiency virus type 1. J Virol (1992) 0.81
Differential regulation of CC chemokine gene expression in human immunodeficiency virus-infected myeloid cells. Virology (1999) 0.81
Ectopic expression of interferon regulatory factor-1 potentiates granulocytic differentiation. Biochem J (2001) 0.81
Inhibition of HIV-1 transmission by interferon and 3'-azido-3'-deoxythymidine during de novo infection of promonocytic cells. Virology (1990) 0.81
Glycogen-rich clear cell rhabdomyosarcoma of the mediastinum. Potential diagnostic pitfall. Am J Surg Pathol (1994) 0.81
Resistance to infection by HIV-1 of peripheral blood mononuclear cells from HIV-1-infected patients is probably mediated by neutralizing antibodies. J Immunol (1990) 0.81
Heterodimerization and transcriptional activation in vitro by NF-kappa B proteins. J Cell Physiol (1992) 0.80
Association between HTLV-1 Tax and I kappa B alpha is dependent on the I kappa B alpha phosphorylation state. Virology (1998) 0.80